US Stocks

ImmunityBio, Inc.

ImmunityBio is a clinical-stage biotechnology company that develops therapies and vaccines to treat cancers and infectious diseases. Their platforms include immunotherapy and cell therapy technology, and they have various collaborations and license agreements. Founded in 2014, the company is headquartered in San Diego, California.